Patent Assignment
Reel/Frame 015074/0090
Assignment of Assignor's Interest
Recorded: 2004-08-19
Pages: 5
Assignor
ONCOPHARM SAS
Executed: 2004-02-25
Assignee
STRAGEN PHARMA SA
3 RUE HUGO-DE-SENGER, 1205 GENEVA, SWITZERLAND
Covered Properties
(6)
Novel Cephalotaxane Derivatives and Process for Their Preparation
Patent:
6,831,180 →
Application:
09/270,006 →
New Cephalotaxanes: Their Method of Preparation and Their Use in Treatment of Cancers, Leukemias, Parasites, Including Those Resistant to Usual Chemotherapeutic Agents, and as Reversal Agents
Patent:
6,579,869 →
Application:
09/710,870 →
Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivatives
Application:
09/801,751 →
Publication:
US 2002/0128258
Novel Cephalotaxane Derivatives and Process for Their Preparation
Treatment of Chronic Myelogenous Leukemia, Resistant or Intolerant to ST1571, Involving Homoharringtonine Alone or Combined with Other Agents
Cephalotaxanes, Their Method of Preparation and Their Use in Treatment of Cancers, Leukemias, Parasites Including Those Resistant to Usual Chemotherapeutic Agents and as Reversal Agents
Related Assignments
(16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 31, 2001
From: ROBIN, JEAN-PIERRE; DHAL, ROBERT; DROUYE, FREDDY; MARIE, JEAN-PIERRE
To: ONCOPHARM CORPORATION
Reel/Frame 011487/0313 →
Assignment of Assignor's Interest
Jul 11, 2001
From: ROBIN, JEAN-PIERRE; MARIE, JEAN-PIERRE; RADOSEVIC, NINA; BLANCHARD, JULIE
To: ONCOPHARM CORPORATION
Reel/Frame 011981/0531 →
Assignment of Assignor's Interest
Dec 5, 2001
From: ROBIN, JEAN-PIERRE; BLANCHARD, JULIE; CAVOLEAU, SYLVIE; CHAUVIAT, LUDOVIC
To: ONCOPHARM CORPORATION
Reel/Frame 012345/0499 →
Assignment of Assignor's Interest
Sep 16, 2003
From: ROBIN, JEAN-PIERRE; MAHON, FRANCOIS-XAVIER; MAISONNEUVE, HERVE; MALOISEL, FREDERICK
To: ONCOPHARM CORPORATION
Reel/Frame 014793/0809 →
Assignment of Assignor's Interest
Aug 18, 2004
From: ROBIN, JEAN-PIERRE; BLANCHARD, JULIE; CAVOLEAU, SYLVIE; CHARBONNEL, SANDRA
To: ONCOPHARM CORPORATION
Reel/Frame 015082/0099 →
Assignment of Assignor's Interest
Aug 19, 2004
From: ONCOPHARM CORPORATION
To: ONCOPHARM SAS
Reel/Frame 015074/0095 →
Assignment of Assignor's Interest
Aug 27, 2009
From: STRAGEN PHARMA S.A.
To: CHEMGENEX PHARMACEUTICALS LTD.
Reel/Frame 023148/0315 →
Release of Patent Security Agreement
Nov 10, 2011
From: MORGAN STANLEY BANK INTERNATIONAL LIMITED, AS SECURITY TRUSTEE
To: STRAKAN INTERNATIONAL LIMITED
Reel/Frame 027212/0299 →
Assignment of Assignor's Interest
Oct 31, 2012
From: CHEMGENEX PHARMACEUTICALS PTY LTD
To: IVAX INTERNATIONAL GMBH
Reel/Frame 029218/0709 →
Change of Name
Dec 5, 2016
From: IVAX INTERNATIONAL GMBH
To: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Reel/Frame 040831/0020 →
Commercial Register Changes
Sep 18, 2017
From: IVAX PHARMACEUTICALS GMBH
To: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Reel/Frame 043889/0617 →
Commercial Register Changes
Sep 18, 2017
From: IVAX INTERNATIONAL GMBH
To: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Reel/Frame 043889/0127 →
Change of Name
Sep 18, 2017
From: CHEMGENEX PHARMACEUTICALS LTD
To: CHEMGENEX PHARMACEUTICALS PTY LTD
Reel/Frame 043888/0205 →
Assignment of Assignor's Interest
Sep 18, 2017
From: CHEMGENEX PHARMACEUTICALS PTY LTD
To: IVAX INTERNATIONAL GMBH
Reel/Frame 043613/0719 →
Corrective Assignment to Correct the Assignor Name Previously Recorded at Reel: 043889 Frame: 0617. Assignor(S) Hereby Confirms the Change of Nane.
Nov 3, 2017
From: IVAX INTERNATIONAL GMBH
To: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Reel/Frame 044710/0595 →
Change of Name
Nov 3, 2017
From: CHEMGENEX PHARMACEUTICALS LTD
To: CHEMGENEX PHARMACEUTICALS PTY LTD
Reel/Frame 044366/0250 →